LSLetícia Lopes Dantas Santos

Letícia Lopes Dantas Santos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Letícia Lopes Dantas Santos has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Influence of fasting during the night shift on next day eating behavior, hunger, and glucose and insulin levels: a randomized, three‐condition, crossover trial

    by Bruno Simão Teixeira, Catarina Mendes Silva, Alinne Tatiane Faria Silva, Letícia Lopes Dantas Santos, Yara Cristina de Paiva Maia, Mario Pedrazzoli, Kenneth P. Wright, Cibele Aparecida Crispim

    Aims To investigate the influence of fasting during the night shift on eating behavior, hunger, glucose and insulin levels the following day. Methods Study with 10 male police officers who have been working at night. Participants were tested under three different conditions separated by at least 6 days of washout in a randomized, crossover design: “Night Shift Fasting” (NSF)—two nights of fasting during the night shift; “Night Shift Eating” (NSE)—two nights with the consumption of a standardized meal during the night shift (678 ± 42 kcal consumed at ~ 0200 h); and “Nighttime Sleep” (NS)—two nights of sleep. The morning after, blood glucose and insulin and hunger ratings were assessed, and food intake was assessed with an ad libitum test meal. Food intake was also assessed throughout the remainder of the day using a food record. Generalized Estimating Equations were used to analyze the effect of experimental condition. Results Food intake during the test meal, especially of proteins and fats, was higher after fasting during the night shift compared to the other conditions (p < 0.05), whereas desire to eat scores were lower after the NSF compared to NSE condition (p = 0.043). Hunger levels were lower after the NSF compared to the NS condition (p = 0.012). Insulin and HOMA-IR were also lower in the morning after NSF (p < 0.001). Conclusion Fasting during the night shift leads to not only a higher intake of energy and macronutrients both in the early morning after work and throughout the next day, but also lower insulin levels and HOMA-IR in the morning. Registration number of clinical trial NCT03800732. Initial release: 01/09/2019. Last release: 02/23/2022


  • Open Access

    A Lower Serum Antioxidant Capacity as a Distinctive Feature for Women with HER2+ Breast Cancer: A Preliminary Study

    by Letícia L. D. Santos, Alinne T. F. Silva, Izabella C. C. Ferreira, Adriele V. Souza, Allisson B. Justino, Donizeti W. Santos, Luiz Ricardo Goulart, Carlos Eduardo Paiva, Foued S. Espíndola, Yara C. P. Maia

    The overexpression of HER2 in breast cancer (BC) can contribute to redox imbalance, which is related to damage and structural modification in many biomolecules. To the best of our knowledge, this is the first study that has investigated the infrared spectrum wavenumbers obtained by ATR-FTIR and their relationship with the levels of redox status markers such as reduced glutathione, superoxide dismutase (SOD), catalase, Ferric Reducing Antioxidant Power (FRAP), and protein carbonyl among women with HER2+ BC, HER2− BC, and benign breast disease (BBD). The study was conducted with 25 women, 17 of whom were diagnosed with BC (6 HER2+ and 11 HER2−) and 8 with BBD. Our results indicate HER2+ BC cases could be distinguished from HER2− BC and BBD cases by their serum’s antioxidant capacity [HER2+ BC vs. HER2− BC (AUC = 0.818; specificity = 81.82%; sensitivity = 66.67%); HER2+ BC vs. BBD (AUC = 0.875; specificity = 75%; sensitivity = 83.33%)]. The changes in biochemical terms that occur in serum as a result of the scarcity of antioxidants are related to a peculiar fingerprint in the infrared spectrum obtained by ATR-FTIR. In the serum of women with BBD, the SOD enzyme level is the highest, and this characteristic allowed us to distinguish them from HER2− BC. Finally, data regarding the serological antioxidant capacity of FRAP and the infrared spectrum by ATR-FTIR will allow us to assess biochemical changes that occur before clinical signs, indicating whether changes in therapy or interventions are necessary.


  • Open Access

    A Novel Detection Method of Breast Cancer through a Simple Panel of Biomarkers

    by Alinne T. F. Silva, Cláudia M. Rodrigues, Izabella C. C. Ferreira, Letícia L. D. Santos, Donizeti W. Santos, Thaise G. Araújo, Paula P. L. Canto, Carlos E. Paiva, Luiz R. Goulart, Yara C. P. Maia

    Circulating tumor cells (CTCs) have been identified as responsible for the spread of tumors to other organs of the body. In this sense, the development of sensitive and specific assays for their detection is important to reduce the number of deaths due to metastases. Here, we assessed whether the detection of CTCs in peripheral blood can serve in the construction of a panel of diagnosis and monitoring treatments of breast cancer (BC), focusing on the expression of markers of epithelial–mesenchymal transition. Through analyzing the blood from women without breast alterations (control), women with benign alterations, women with breast cancer without chemotherapy, and women with breast cancer with chemotherapy, we identified the best markers by transcriptional levels and determined three profiles of CTCs (mesenchymal, intermediate, and epithelial) by flow cytometry which, combined, can be used for diagnosis and therapy monitoring with sensitivity and specificity between 80% and 100%. Therefore, we have developed a method for detecting breast cancer based on the analysis of CTC profiles by epithelial–mesenchymal transition markers which, combined, can be used for the diagnosis and monitoring of therapy.


  • Open Access

    Overweight Women with Breast Cancer on Chemotherapy Have More Unfavorable Inflammatory and Oxidative Stress Profiles

    by Letícia L. D. Santos, Isis D. D. Custódio, Alinne T. F. Silva, Izabella C. C. Ferreira, Eduarda C. Marinho, Douglas C. Caixeta, Adriele V. Souza, Renata R. Teixeira, Thaise G. Araújo, Nitin Shivappa, et al.

    Chronic inflammation and redox imbalance are strongly influenced by diet and nutritional status, and both are risk factors for tumor development. This prospective study aimed to explore the associations between inflammatory and antioxidant markers and nutritional status in women with breast cancer undergoing chemotherapy. The women were evaluated at three times: T0, after the infusion of the first cycle; T1, after infusion of the intermediate cycle; and T2, after the infusion of the last chemotherapy cycle. The consumption of antioxidant nutrients and the Total Dietary Antioxidant Capacity reduced between T0 and T2 and the Dietary Inflammatory Index scores increased throughout the chemotherapy. Blood samples taken at the end of the chemotherapy showed lower levels of glutathione reductase and reduced glutathione, with greater quantification of the transcripts for Interleukin-6 and Tumor Necrosis Factor α. It should be emphasized that the Total Dietary Antioxidant Capacity is lower and the Dietary Inflammatory Index is higher in the group of overweight patients at the end of the follow-up, besides showing lower levels of the redox status, especially the plasma levels of glutathione reductase (p = 0.039). In addition, trends towards higher transcriptional levels of cytokines in peripheral blood were observed more often in overweight women than in non-overweight women. In this study of 55 women with breast cancer, nine (16%) with metastases, diet became more pro-inflammatory with fewer antioxidants during the chemotherapy. Briefly, we have shown that chemotherapy is critical for high-risk overweight women due to their reduced intake of antioxidant nutrients, generating greater inflammatory and oxidative stress profiles, suggesting the adoption of healthier dietary practices by women with breast cancer throughout their chemotherapy.


  • Open Access

    ALDH1 expression and activity increase during tumor evolution in sarcoma cancer stem cell populations

    by L. Martinez-Cruzado, J. Tornin, L. Santos, A. Rodriguez, R. Rodriguez